Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹2,186 Cr₹-1,560 Cr₹1,587 Cr₹-177 Cr₹319 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of GLAND PHARMA is ₹2,186 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹2,186 Cr
Mar2024₹-1,560 Cr
Mar2023₹1,587 Cr
Mar2022₹-177 Cr
Mar2021₹319 Cr

How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹2,186 Cr
Positive
Mar2024 ₹-1,560 Cr
Negative
Mar2023 ₹1,587 Cr
Positive
Mar2022 ₹-177 Cr
Negative
Mar2021 ₹319 Cr -

Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹36,315.7 Cr -2.7% -2.1% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,639.0 Cr 0.9% -3.1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹179,647.0 Cr 2% -2.1% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,366.0 Cr -2.9% -0.3% 36.4% Stock Analytics
CIPLA ₹109,528.0 Cr -2.4% -3.8% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,819.0 Cr -0.5% -5% -6.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.7%

-2.1%

31.8%

SENSEX

4.9%

2.8%

-6.2%


You may also like the below Video Courses